Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/24/23
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 10/11/22
End: 06/20/23
Due: 06/20/24
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Efficacy of RGn600 in Patients With Mild-to-moderate Alzheimer's Disease | NCT05926011 | REGEnLIFE SAS | user2@example.com | None | 2023-07-24 | 2026-12-31 | 2027-12-31 | - | - | 2025-07-14 |
| Pilot Clinical Investigation Evaluating the Safety and Performance of RGn550 in Treating Sportspeople Suffering From Acute Concussion Syndrome | NCT05647304 | REGEnLIFE SAS | user2@example.com | None | 2022-10-11 | 2023-06-20 | 2024-06-20 | - | - | 2025-07-14 |